Single-Cell RNA Sequencing of Cardiac Organoids to Determine the Genetic Basis for Cell-Specific Responses to Anticancer Drugs
心脏类器官的单细胞 RNA 测序以确定抗癌药物细胞特异性反应的遗传基础
基本信息
- 批准号:10679493
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2026-09-29
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdverse effectsAffectAllelesAnthracyclineAntineoplastic AgentsArrhythmiaBiological MarkersBiological ModelsBlood VesselsCancer PatientCancer SurvivorCandidate Disease GeneCardiacCardiac MyocytesCardiotoxicityCardiovascular PhysiologyCardiovascular systemCatalogsCell Culture TechniquesCell Differentiation processCell LineCellsCessation of lifeClassificationDataDiseaseDoxorubicinDrug usageEndodermEndothelial CellsEnvironmentFibroblastsFluorouracilFunctional disorderFutureGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenotypeHeartHeart failureHeritabilityHypertensionIndividualIntuitionLong-Term EffectsMalignant NeoplasmsMapsMeasuresMediatingMesoderm CellModelingMorbidity - disease rateNeural Crest CellOncologyOrganoidsPathway interactionsPatientsPharmaceutical PreparationsPharmacogenomicsPharmacotherapyPredispositionPrimitive foregut structureProceduresReportingReproducibilityRiskRisk FactorsSample SizeSamplingSupporting CellSymptomsSystemTestingTimeTissuesToxic effectTranscriptTreatment ProtocolsVariantVascular Endothelial CellVascular SystemWorkanticancer treatmentbevacizumabcancer therapycardiovascular risk factorcell typeclinical phenotypedifferentiation protocoldisorder riskeffective therapyexperimental studygenetic architecturegenetic variantgenotyped patientsimprovedindividual patientinduced pluripotent stem cellinter-individual variationmortalitynovelpersonalized medicineprematureresponseside effectsingle-cell RNA sequencingstem cellstraittranscriptomics
项目摘要
PROJECT SUMMARY
Anticancer drug-induced cardiovascular toxicity (CT) is a major side effect for many patients undergoing
treatment for oncological disorders. CT symptoms vary widely across individuals, both in presentation and in
time to onset. Risk of CT complicates treatment protocols and places cancer patients under additional duress.
Genetic background is broadly understood to be a component of CT susceptibility, but specific variants and
mechanisms remain largely unknown. To understand the genetic basis for drug-induced CT, we need to
understand how anticancer drugs stimulate transcriptomic responses in multiple cardiovascular cell types from
individuals of different genetic backgrounds. Inter-individual variability in response to anticancer drugs is
mediated by genetic variants that affect gene regulation in a drug-dependent manner (response eQTLs). In
other words, genetic variants respond to anticancer drugs by regulating the activity of specific genes. Notably,
different cell types can vary in their response eQTLs to anticancer drugs. I propose to determine the genetic
basis for transcriptomic responses to the anticancer drugs doxorubicin (DOX), 5-fluorouracil (5-FU), and
bevacizumab (BVC) in multiple cardiac cell types from a genetically diverse panel of 70 individuals.
Identification of CT-associated response eQTLs necessitates a high-throughput model system comprised of
multiple cardiac cell types. For Aim 1 of my proposal, I have developed a culture environment and guided
differentiation protocol conducive to cardiac lineage and supporting cell types. This procedure reproducibly
transforms induced pluripotent stem cell (iPSC)-derived embryoid bodies (EBs) into cardiac organoids.
Preliminary data demonstrate that the cardiac organoids harbor cardiomyocytes, fibroblasts, vascular
endothelial cells, and other mesodermal cell types. In Aim 2, I will perform single-cell RNA sequencing
(scRNA-seq) on a panel of 70 cardiac organoids cultured in control and drug-treated conditions. Repeating
this experiment across multiple individuals will allow me to identify the response eQTLs that regulate how
different cardiovascular cell types respond to each drug. In Aim 3, I will quantify gene expression levels and
identify response eQTLs that regulate transcriptional changes to each anticancer drug in cardiovascular cell
types. Response eQTLs (which are anchored by genotype) provide a catalog of loci that interact either directly
or indirectly with the treatment. These response eQTLs may reveal specific genes and pathways important for
normal cardiovascular function. Elucidating the genetic architecture underlying CT risk will provide intuition on
cardiotoxic mechanisms and associated genes and inform future studies that aim to classify individual patient
susceptibility.
项目摘要
抗癌药物诱导的心血管毒性(CT)是许多接受化疗的患者的主要副作用。
肿瘤疾病的治疗。CT症状在个体之间差异很大,无论是在表现还是在
至发作时间CT的风险使治疗方案复杂化,并使癌症患者受到额外的胁迫。
遗传背景被广泛理解为CT易感性的组成部分,但特定的变体和
其机制在很大程度上仍然未知。为了了解药物诱导CT的遗传基础,我们需要
了解抗癌药物如何刺激多种心血管细胞类型的转录组反应,
不同遗传背景的个体。对抗癌药物反应的个体间差异是
由以药物依赖性方式影响基因调控的遗传变异介导(响应eQTL)。在
换句话说,遗传变异通过调节特定基因的活性对抗癌药物作出反应。值得注意的是,
不同的细胞类型在它们对抗癌药物的响应eQTL方面可以不同。我建议确定基因
对抗癌药物阿霉素(DOX)、5-氟尿嘧啶(5-FU)和
贝伐珠单抗(BVC)在多种心脏细胞类型的遗传多样性小组的70个人。
CT相关响应eQTL的鉴定需要高通量模型系统,其包括
多种心脏细胞类型。对于我的建议的目标1,我已经建立了一个文化环境,
分化方案有助于心脏谱系和支持细胞类型。该程序可重复
将诱导多能干细胞(iPSC)衍生的胚状体(EB)转化为心脏类器官。
初步数据表明,心脏类器官含有心肌细胞,成纤维细胞,血管内皮细胞,
内皮细胞和其它中胚层细胞类型。在目标2中,我将进行单细胞RNA测序
在对照和药物处理的条件下培养的70个心脏类器官的小组上进行scRNA-seq。重复
这个在多个个体中进行的实验将使我能够确定调节反应的eQTL,
不同的心血管细胞类型对每种药物有反应。在目标3中,我将量化基因表达水平,
鉴定心血管细胞中调节对每种抗癌药物转录变化的响应eQTL
类型响应eQTL(由基因型锚定)提供了一个基因座目录,
或间接与治疗有关。这些响应eQTL可以揭示特定的基因和途径,
心血管功能正常。阐明CT风险背后的遗传结构将提供以下方面的直觉:
心脏毒性机制和相关基因,并为未来旨在对个体患者进行分类的研究提供信息
易感性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erik McIntire其他文献
Erik McIntire的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Studentship